...
首页> 外文期刊>Annals of Dermatology >The Efficacy of Intense Pulsed Light for Treating Erythematotelangiectatic Rosacea Is Related to Severity and Age
【24h】

The Efficacy of Intense Pulsed Light for Treating Erythematotelangiectatic Rosacea Is Related to Severity and Age

机译:强脉冲光治疗红斑毛细血管扩张性酒渣鼻的功效与年龄和年龄有关

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Rosacea is a chronic cutaneous disease. Therapeutic modalities should be chosen based on the identified sub-types and clinical features in each patient. Vascular lasers, including intense pulsed light (IPL), are reportedly safe and effective in treating erythematotelangiectatic rosacea (ETR). Objective In this study, we assess the comparative efficacy of IPL related to several factors including clinical severity and the age of patients with ETR. Methods Patients with ETR were classified into two groups according to the National Rosacea Society Severity Guideline. Severity score and erythema index (EI) were measured using a clinical scorecard and mexameter. For additional evaluation of therapeutic efficacy, investigator and patient global assessments (IGA, PGA) were checked. Efficacy of IPL was analyzed according to severity score, EI, IGA, and PGA related to sex, age, lactic acid stinging test, and severity. Results Analyses of the efficacy of IPL according to severity score, EI, IGA, and PGA based on sex, age, lactic acid stinging test, and severity revealed significant differences with age and severity only. Conclusion This study supports the efficacy of IPL treatment for patients with ETR. IPL may be more effective in patients with more severe ETR and in younger patients with ETR.
机译:背景酒渣鼻是一种慢性皮肤疾病。治疗模式应根据每个患者中确定的亚型和临床特征进行选择。据报道,包括强脉冲光(IPL)在内的血管激光在治疗红斑性毛细血管扩张性酒渣鼻(ETR)方面是安全有效的。目的在本研究中,我们评估IPL与包括临床严重程度和ETR患者年龄在内​​的几个因素有关的比较疗效。方法根据国家酒渣鼻协会严重程度指南将ETR患者分为两组。严重程度评分和红斑指数(EI)使用临床评分卡和比色计进行测量。为了进一步评估治疗效果,检查了研究者和患者的整体评估(IGA,PGA)。根据严重程度评分,EI,IGA和PGA与性别,年龄,乳酸刺激试验和严重程度相关,分析IPL的疗效。结果根据性别,年龄,乳酸刺激试验和严重程度对IPL的严重程度评分,EI,IGA和PGA进行疗效分析,发现仅与年龄和严重程度存在显着差异。结论本研究支持IPL治疗ETR患者的疗效。 IPL对ETR较重的患者和ETR较年轻的患者可能更有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号